Most PDAC patients die within the first two years, and only a small subgroup of patients exceeds this survival rate. So far, the immune-related genes and pathways long-term survivorship in PDAC are unknown. In this webinar, Dr. Mustafa presents the first comprehensive study that compares the expression and the spatial infiltration of immune cells in PDAC patients with different survival rates. The study demonstrates the use of the GeoMx™ Digital Spatial Profiler (DSP) to determine the spatial location of specific immune cells.
For Research Use Only. Not for Use in Diagnostic Procedures.